Clicky

Aroa Biosurgery Limited(ARX)

Description: Aroa Biosurgery Limited, a regenerative medicine company, develops and manufactures medical devices for wound and tissue repair in the United States and internationally. Its products include Endoform Natural and Endoform Antimicrobia for treating acute and chronic wounds; Myriad, an implant and dermal procedures for soft tissue repair, reinforcement, and complex wounds; and Reinforced Bioscaffolds, a biologics and synthetics product used in surgical ventral hernia repair solutions. The company was founded in 2008 and is based in Auckland, New Zealand.


Keywords: Medicine Cement Clinical Medicine Surgery Medical Device Regenerative Medicine Implant Wound Chronic Wounds Digestive System Surgery Chronic Wound Hernia Regenerative Acute And Chronic Wounds Hernia Repair Hernias Scaffold Soft Tissue Repair

Home Page: aroabio.com

ARX Technical Analysis

64 Richard Pearse Drive
Auckland, 2022
New Zealand
Phone: 64 9 869 3035


Officers

Name Title
Dr. Brian Ward Founder, CEO, MD & Exec. Director
Mr. James Agnew BCom, LLB CFO & Joint Company Sec.
Dr. Barnaby C.H. May Ph.D. Chief Scientific Officer
Ms. Tracy Weimar BA, MBA Company Sec.

Exchange: AU

Country: AU

Currency: Australian Dollar (A$)

GIC Sector: Materials
GIC Group: Materials
GIC Industry: Metals & Mining
GIC Sub-Industry: Gold
Forward PE: 0
Trailing PE: 0
Price-to-Book MRQ: 4.086
Price-to-Sales TTM: 7.1673
IPO Date:
Fiscal Year End: March
Full Time Employees: 0
Back to stocks